Gratus Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Hold
0
156
2024
Q1
Hold
0
-$1.63M 329
2023
Q4
Hold
0
126
2023
Q3
Hold
0
119
2023
Q2
Hold
0
86
2020
Q2
Sell
-39,400
Closed -$5.17M 174
2020
Q1
$5.17M Buy
+39,400
New +$5.59M 0.96% 45

Other funds holding JNJ

Gratus Capital's JNJ Position: Q2 2024 in Review

Gratus Capital increased its Johnson & Johnson (JNJ) stake by 6.5% in Q2 2024, buying an estimated $1.19M and bringing the position to 129,670 shares worth $19M. The position accounts for 0.76% of the portfolio, ranked #35.

Gratus Capital first reported a position in JNJ in Q4 2014 and has held it in 39 quarters since. The position peaked at $23.7M in Q4 2022. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Gratus Capital held 129,670 shares of Johnson & Johnson worth $19M as of Q2 2024.
  • Gratus Capital bought 7,968 Johnson & Johnson shares in Q2 2024, an estimated $1.19M.
  • Johnson & Johnson made up 0.76% of Gratus Capital's portfolio in Q2 2024, its #35 holding.
  • Gratus Capital first reported a position in Johnson & Johnson in Q4 2014 and has held it in 39 quarters since.
  • Gratus Capital's Johnson & Johnson position peaked at $23.7M in Q4 2022.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.